Two-year mortality after transcatheter aortic valve implantation versus medical therapy for high-surgical risk or inoperable aortic stenosis patients.
Rainer Hoffmann(MedStar Washington Hospital Center), Guido Dohmen(RWTH Aachen University), Emilia Stegemann, Kathrin Brehmer, Bader O. Almutairi(King Saud University), Rüdiger Autschbach(RWTH Aachen University), Ömer Aktug, Nikolaus Marx(RWTH Aachen University), Robert Stöhr(Friedrich-Alexander-Universität Erlangen-Nürnberg), Ralf Herpertz
PubMed
January 1, 2013
Cited by 6
Related Papers
Empagliflozin in Heart Failure with a Preserved Ejection Fraction
|New England Journal of Medicine|2021|4.6k
2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes
|European Heart Journal|2023|1.4k
T-lymphocyte Infiltration in Visceral Adipose Tissue
|Arteriosclerosis Thrombosis and Vascular Biology|2008|679
Comprehensive Transcriptional Analysis of Early-Stage Urothelial Carcinoma
|Cancer Cell|2016|660
Patterns of p53 Mutations Separate Ovarian Serous Borderline Tumors and Low- and High-grade Carcinomas and Provide Support for a New Model of Ovarian Carcinogenesis
|The American Journal of Surgical Pathology|2005|411